MULLEN JAMES C 4
4 · Editas Medicine, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
MULLEN JAMES C
Director
Transactions
- Sale
Common Stock
2022-01-03$26.95/sh−18,252$491,979→ 75,898 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on March 4, 2021, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 22, 2021. The sale does not represent a discretionary trade by the Reporting Person.